Microporous Polysaccharide Hemospheres Epistaxis

Withdrawn before enrolling · Not applicable

Conditions studied: Epistaxis

In brief

The purpose of this study is to compare a new treatment for nosebleeds to the treatment that has been used for many years.

Key facts

Study ID

NCT02466464

Run by

Emory University

People needed

0

Starts

2015-01-01

Expected to finish

2015-12-31

Last updated by the study team

2017-01-26

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• acute epistaxis who have failed conservative measures (including application of pressure and application of oxymetazoline spray) and for which the Otolaryngology service has been consulted
• must be alert and oriented
• hemodynamically stable with a hemoglobin greater than 9 g/dL
• cooperative

You may not qualify if…

• unable to consent or cooperate
• history of hereditary hemorrhagic telengectasias
• hemophilia
• clotting factor deficiencies
• history of prior surgery for epistaxis control
• nasal trauma
• recent sinonasal surgery
• hemodynamic instability
• posterior bleed (as determined by Ear, Nose, Throat physician)
• visibly bleeding vessel
• allergy to product
• current diabetic ketoacidosis

Where it is running

• Emory University Department of Otolaryngology Clinic — Atlanta, Georgia, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.